McDermott Will & Emery represented Pasithea Therapeutics Corp. in the transaction. Pasithea Therapeutics Corp., a biotechnology company focused on the discovery, research and development of innovative...
Pasithea Therapeutics’ Acquisition of AlloMek Therapeutics
Mullen Automotive’s $148.2 Million Acquisition of a Controlling Interest in Bollinger Motors
McDermott Will & Emery represented Mullen Automotive, Inc. in the transaction. Mullen Automotive, Inc. (NASDAQ: MULN), an emerging electric vehicle (EV) manufacturer, announced its acquisition of a...
Portage Biotech’s Acquisition of Tarus Therapeutics
McDermott Will and Emery represented Portage Biotech Inc. in the transaction. Portage Biotech Inc., a clinical-stage immuno-oncology company developing therapies to improve patient lives and increase...
Pasithea Therapeutics’ Acquisition of Alpha-5 Integrin
McDermott Will & Emery represented Pasithea Therapeutics Corp. in the transaction. Pasithea Therapeutics Corp. (Pasithea), a US biotechnology company focused on the research and discovery of...
Centerline Biomedical’s $33 Million Series B Equity Financing
Centerline Biomedical, Inc., a private medical technology company, closed $33 million Series B equity financing, led by Cleveland Clinic, a nonprofit multispecialty academic medical center that integrates clinical...
Altaris Capital Partners’ $475 Million Acquisition of Solesis
McDermott Will & Emery represented Compagnie Générale des Établissements Michelin SCA (Michelin) in the transaction. Cleary Gottlieb represented Altaris Capital Partners in the transaction. Compagnie Générale...